Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer

NCT06495346 | Completed

• 1 other identifier: 9002
• Study Type: observational
• Target: 37
• Locations: 1 country
• Sites: 1

Brief Summary

This exploratory study will identify and characterise disorders frequently reported by patients as contributing to or altering their quality of life. This will enable a decision tree to be drawn up for diagnosis, referral and treatment of the sleep disorders collected, tailored to patients in this population. This decision tree should help to improve the management of patients with a cancer diagnosis presenting with sleep disorders.

Conditions

Cell Lung Cancer; Sleep Disorders

Outcome Measures

Primary Outcomes (1)

• Score sleep quality criteria (Pittsburgh Sleep Quality Index)

  The overall score ranging from 0 to 21 points. A score of 0 means that there is no difficulty sleeping, and 21 indicates, on the contrary, major difficulties.

  Every 14 days for 2 months

Interventions

self-questionnaires exploring OTHER

At each stage, subjects are asked to fill in self-questionnaires exploring the quality of their sleep, their potential distressing symptoms, their psychological state and the quality of their life at that moment. They complete the self-questionnaires at t

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with a diagnosis of non-small cell lung cancer followed and treated by the Oncopneumology Department of the Nouvel Hôpital Civil in Strasbourg

You may qualify if:

• Patient aged 18 and over.
• Being monitored and treated for non-small cell lung cancer.
• With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30).
• With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG \<2).
• Able to understand the study documents written in French
• Able to complete the study questionnaires written in French.
• Contactable by telephone throughout the study
• Affiliated to a social security scheme or entitled beneficiary
• Not opposed to taking part in the study

You may not qualify if:

• Patient refusing to take part in the study
• With a mental illness of the psychosis type monitored and treated prior to the study
• Patient under guardianship or curatorship
• Patient under court protection

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

HUS

Strasbourg, Grand Est, 67117, France

Location

MeSH Terms

Conditions

Sleep Wake Disorders

Condition Hierarchy (Ancestors)

Nervous System Diseases; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Mental Disorders

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 13, 2024
• First Posted: July 10, 2024
• Study Start: December 11, 2023
• Primary Completion: March 25, 2025
• Study Completion: March 25, 2025
• Last Updated: June 12, 2026

Record last verified: 2026-06

Locations

FR (1)